Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-09-06FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly, expanding the regulatory approval for the product.
-
FDA approval · 2013-09-05FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for JENTADUETO (linagliptin/metformin hydrochloride) from Boehringer Ingelheim, resulting in a label…
-
FDA approval · 2013-08-21FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro (and its diluent) from Eli Lilly, signaling an update to the product's regulatory…
-
FDA approval · 2013-08-21FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-08-19FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUVIA (sitagliptin) from Merck Sharp & Dohme LLC. The supplemental action updates the drug…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-08-16FDA Approved: GLYBURIDE — Supplemental Application (TEVA Pharmaceuticals USA Inc)
FDA approves TEVA Pharmaceuticals USA Inc's supplemental application for GLYBURIDE. The action updates the approved glyburide product throug…
-
FDA approval · 2013-08-15FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Actoplus Met, a fixed-dose combination of pioglitazone and metformin hydrochloride, submitte…
-
FDA approval · 2013-08-15FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA granted supplemental approval for insulin lispro from Eli Lilly (BLA020563), updating the product's regulatory status.
-
FDA approval · 2013-08-15FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-08-15FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2013-08-15FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-08-15FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) to incorporate the KwikPen delivery device for the pre…
-
FDA approval · 2013-08-15FDA Approved: ALOGLIPTIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for alogliptin by Padagis Israel Pharmaceuticals Ltd.
-
FDA approval · 2013-08-15FDA Approved: ALOGLIPTIN AND PIOGLITAZONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for the alogliptin and pioglitazone combination product, manufactured by Padagis Israel Pharmaceutic…
-
FDA approval · 2013-08-14FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Lantus SoloStar (insulin glargine) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2013-07-31FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for Bromocriptine Mesylate, resulting in updated labeling for the product.
-
FDA approval · 2013-07-30FDA Approved: NATEGLINIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approves a supplemental application for Nateglinide by Strides Pharma Science Limited.
-
FDA approval · 2013-07-26FDA Approved: GLIPIZIDE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for Glipizide (generic) under an Abbreviated New Drug Application (ANDA).
-
FDA approval · 2013-07-26FDA Approved: GLIPIZIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for glipizide submitted by Actavis Pharma, Inc., extending the existing approval.
-
FDA approval · 2013-07-22FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
FDA approves a supplemental application from Prasco Laboratories for a pioglitazone and glimepiride fixed-dose combination product. This all…
-
FDA approval · 2013-07-19FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET XR (sitagliptin and metformin hydrochloride) from Merck Sharp & Dohme LLC.
-
FDA approval · 2013-07-19FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' metformin hydrochloride as an original-generic drug application.
-
FDA approval · 2013-07-18FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) from Sanofi-aventis U.S. LLC.
-
FDA approval · 2013-07-18FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company.
-
FDA approval · 2013-06-28FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc. to update lab…